Eastman Chemical Company

Eastman Chemical Company (EMN) Market Cap

Eastman Chemical Company has a market capitalization of .

No quote data available.

CEO: Mark J. Costa

Sector: Basic Materials

Industry: Chemicals - Specialty

IPO Date: 1993-12-14

Website: https://www.eastman.com

Eastman Chemical Company (EMN) - Company Information

Market Cap: -|Sector: Basic Materials

Company Profile

Eastman Chemical Company functions as a worldwide provider of specialized materials. Its Additives & Functional Products division offers a comprehensive range, including hydrocarbon and rosin resins, organic acid-based solutions, and amine-derived building blocks. This segment also provides agricultural chemicals like metam-based soil fumigants, thiram and ziram fungicides, and plant growth regulators. Additional offerings include specialty coalescents, various commodity and specialty solvents, paint additives, specialty polymers, heat transfer and aviation fluids, and rubber additives such as insoluble sulfur and anti-degradants, along with performance resins. These products cater to diverse sectors such as transportation, personal care, wellness, food, agriculture, construction, water treatment, energy, consumables, durables, and electronics. The Advanced Materials segment produces high-performance products including copolyesters, cellulosic biopolymers, cellulose esters, and polyvinyl butyral (PVB) sheets. It further supplies a variety of window and protective films, including those applied aftermarket, for high-value applications in transportation, consumer durables, electronics, building and construction, medical, pharmaceutical, and general consumables markets. Through its Chemical Intermediates segment, Eastman delivers essential chemical building blocks. This encompasses methylamines and their salts, various higher amines and solvents, olefin and acetyl derivatives, ethylene, and both primary phthalate and non-phthalate plasticizers, including specialized non-phthalate alternatives. These intermediates are vital for industrial chemical processes, construction, health and wellness products, and agrochemical formulations. Lastly, the Fibers segment is a significant producer of cellulose acetate tow, triacetin, cellulose acetate flake, acetic acid, and acetic anhydride, primarily for filtration media, notably cigarette filters. It also furnishes natural and solution-dyed acetate yarns for consumables and health and wellness markets, alongside wet-laid nonwoven media, specialty engineered papers, and cellulose acetate fibers for the transportation, industrial, agriculture, mining, and aerospace industries. Eastman Chemical Company was founded in 1920 and is headquartered in Kingsport, Tennessee.

Analyst Sentiment

73%
Strong Buy

From 15 Active Polls

1Y Forecast: $79.56

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$70

Median

$80

High Bound

$88

Average

$80

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$79.56
▲ +13.74% Upside
Low Target
$70.00
0% Risk
Median Target
$80.00
14% Mid
High Target
$88.00
26% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 EASTMAN CHEMICAL (EMN) — Investment Overview

🧩 Business Model Overview

Eastman Chemical operates a vertically integrated, specialty-focused chemicals model that converts commodity inputs into higher-value intermediates and engineered products. The business is organized around downstream applications where formulations, material properties, and performance specifications matter.

Value is created through (1) scalable upstream production of key chemical building blocks, (2) conversion into application-ready chemicals and materials, and (3) sustained customer qualification through technical support and material performance. For many end markets, customers purchase based on fit-for-purpose properties rather than commodity price alone, which supports repeat demand and lower churn than purely undifferentiated chemical producers.

💰 Revenue Streams & Monetisation Model

Revenue is primarily driven by a mix of transactional and contract-like repeat purchasing, reflecting the diversity of products:

  • Specialty and engineered materials (performance plastics, specialty additives, and differentiated polymers) that typically monetize through value-in-use—higher functionality, broader formulation compatibility, and durability.
  • Intermediates and derivatives that monetize through integrated production scale and conversion efficiency, with pricing influenced by chemical spreads and end-demand.
  • Application-linked products and customer programs where ongoing technical collaboration supports requalification cycles and continuity of supply.

Margin drivers tend to be influenced by: (1) product mix toward specialties, (2) manufacturing leverage and operational reliability, (3) input-output spread management (feedstock and energy vs. product pricing), and (4) the share of sales where customers pay for performance attributes rather than raw chemistry.

🧠 Competitive Advantages & Market Positioning

Eastman’s moat is best understood as a combination of switching costs (customer qualification and performance verification), cost and scale advantages (integrated manufacturing and efficient production), and intangible assets (formulation knowledge, process know-how, and application expertise).

Switching costs / customer qualification: Many of Eastman’s products are embedded in customer processes or final products requiring specific mechanical, chemical, thermal, or optical performance. Requalification, testing, and redesign create friction against switching suppliers.

Cost and logistical infrastructure: As a materials producer, Eastman benefits from the ability to source and convert chemical feedstocks at scale and distribute products through established transportation and distribution networks. Where feedstock economics matter, the integrated production model and purchasing discipline help moderate volatility.

Intangible assets: Technical service, long-cycle development, and application engineering function as durable barriers—competitors can replicate chemistry, but matching performance outcomes and customer acceptance can take meaningful time.

  • Celanese: A focused competitor in acetyl-based and related specialties. Compared with Celanese, Eastman is more diversified across materials and application segments, which can balance end-market cyclicality.
  • BASF: A broad chemicals platform with extensive commodity and intermediate exposure. Eastman typically positions more heavily toward differentiated materials and application value, where pricing is less purely commodity-driven.
  • Dow / Covestro (performance materials peers): Competitors in engineered polymers and performance materials. Eastman competes via application fit and integrated manufacturing, rather than competing solely on scale of commodity-like product.

🚀 Multi-Year Growth Drivers

Over a five- to ten-year horizon, Eastman’s opportunity is anchored in expanding demand for higher-performance materials and molecules, supported by sustainability-linked product cycles and end-market secular trends:

  • Lightweighting and performance substitution: Engineered materials that replace heavier or less capable alternatives in transportation, electronics, and industrial applications.
  • Growth in specialty formulations: Downstream customers increasingly prioritize performance, durability, and chemical resistance—attributes that raise the share of revenue captured through differentiated products.
  • End-market electrification and industrial modernization: Higher-performance polymers and intermediates are used across infrastructure, mobility, and industrial equipment where thermal and mechanical properties are critical.
  • Sustainability and circularity initiatives: Demand for lower-impact materials and recycling-compatible chemistries supports longer-duration product programs and customer collaborations, extending the value proposition beyond short-term pricing.

TAM expansion is less about chasing bulk volume and more about increasing the penetration of performance materials and specialty intermediates in customer value chains where the economic trade-off favors differentiated suppliers.

⚠ Risk Factors to Monitor

  • Feedstock and energy volatility: Chemical spreads can compress if input costs rise faster than product pricing or if downstream demand weakens.
  • Demand cyclicality: End-market exposure (transportation, industrial, housing-adjacent uses, coatings and packaging-related demand) can create earnings variability.
  • Capital intensity and execution risk: Specialty chemicals and materials require sustained investment in maintenance, debottlenecking, and capacity optimization; delays can impair returns.
  • Regulatory and ESG compliance: Environmental permitting, emissions requirements, and chemical handling rules can increase costs or restrict operating flexibility.
  • Technological substitution: Alternate chemistries, bio-based inputs, or process changes by customers can reduce demand for specific product lines, requiring portfolio responsiveness.

📊 Valuation & Market View

The specialty chemicals and materials complex is typically valued on earnings power rather than purely on top-line growth. Market frameworks often reference EV/EBITDA and cash flow durability, adjusted for cyclicality and input sensitivity. For Eastman, key valuation movers are generally:

  • Specialty mix and margin structure (the proportion of sales linked to differentiated products vs. more commodity-exposed categories).
  • Operational performance (utilization, reliability, and cost competitiveness).
  • Input-output spread resilience and disciplined working capital management.
  • Capital allocation credibility (return-focused projects and maintenance discipline that protect cash generation through cycles).

🔍 Investment Takeaway

Eastman’s long-term case rests on durable differentiation in specialty and engineered materials, supported by customer qualification dynamics (switching costs), integrated manufacturing and cost discipline, and application-driven technical capabilities. The investment thesis is most compelling when the business generates resilient margins through specialty mix and operational execution, while navigating the inherent cyclicality of chemicals via portfolio breadth and scale-based advantages.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-06-30

"EMN reported Q2 2026 revenue of $2.513B and net income of $183M, with diluted EPS of $1.59. Revenue rose 15.4% YoY (vs. $2.287B in Q2’25) and increased 15.4% QoQ (vs. $2.177B in Q1’26). Net income grew 30.7% YoY (vs. $140M in Q2’25) and surged 71.0% QoQ (vs. $107M in Q1’26). Profitability improved: gross margin expanded to 22.3% from 22.1% YoY and 19.8% QoQ; operating margin increased to 12.3% from 12.4% YoY (roughly flat) and up from 8.9% QoQ. Net margin rose to 7.3% from 6.1% YoY and from 4.9% QoQ, indicating meaningful cost/volume improvement in the quarter. Cash flow remained solid. Operating cash flow was $224M in Q2’26, translating to $124M in free cash flow after $100M capex. The company continued shareholder distributions: dividends paid were about $96M and buybacks are not reported as occurring in this quarter. Balance sheet quality strengthened with cash rising to $691M and total equity holding near $6.1B. Total shareholder returns appear mixed—price is up 22.6% over 6 months and Y1 change is slightly negative (-3.9%); dividend yield is ~1.25%. Analyst consensus target (~$79.56) remains below the $73.78 close, implying modest valuation support but not strong upside."

Revenue Growth

Good

Q2’26 revenue grew 15.4% YoY and 15.4% QoQ, showing a clear acceleration from Q1 and strong year-over-year demand.

Profitability

Good

Net margin improved to 7.3% (from 6.1% YoY and 4.9% QoQ). Operating margin expanded strongly QoQ to 12.3%, while gross margin is slightly higher vs both periods.

Cash Flow Quality

Positive

Operating cash flow was positive at $224M and free cash flow was $124M. Dividends paid were consistent (~$96M). Buybacks were not indicated in Q2’26.

Leverage & Balance Sheet

Good

Balance sheet resilience improved with higher cash ($691M) and stable total equity (~$6.18B). Despite prior quarter leverage signals, net debt is negative (net cash) in Q2’26.

Shareholder Returns

Neutral

Dividend yield is ~1.25%, but 1-year price change is -3.9% (no strong momentum). 6-month performance is strong (+22.6%), suggesting recent improvements.

Analyst Sentiment & Valuation

Positive

Consensus target ($79.56) is above the $73.78 price, indicating potential upside. However, the implied valuation support is not extreme given mixed 1-year momentum.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

So what: EMN’s Q1 narrative is less about macro demand recovery and more about capturing share and securing volumes in a supply-constrained, higher-energy-cost environment. Methanolysis-related wins are sustaining specialty plastics/rPET growth into Q2 and the back half, with oil-driven relative value helping rPET penetration. Management reiterated 4%–5% circular revenue growth, implying confidence that gains are primarily share/adoption and competitor constraints—not broad end-market strengthening. The biggest softness is Fibers: Middle East customers (10% of segment revenue) face export/logistics constraints, causing lower Q2 buying and a guide reset; management still expects a second-half improvement anchored in global contract minimums, guiding Fibers earnings to $210m–$240m. Chemical Intermediates remains strong but highly path-dependent: Q2 EBIT near ~$50m, and Q3 likely similar unless Strait-related tightness eases. Pricing is actively executed (~$500m started), neutralizing tariff/storm impacts and supporting margins into Q2 and beyond.

AI IconGrowth Catalysts

  • Methanolysis-driven specialty plastics momentum: volume growth in Q1 continuing into Q2 and back half; adoption in Tritan and cosmetic packaging
  • rPET platform value proposition strengthening versus virgin PET as oil rises; continued rPET demand with capacity running to serve
  • Advanced Materials application wins tied to methanolysis, including continued circular/rPET build back-half loaded
  • Chemical Intermediates: improved margins/spreads from Middle East supply constraints and reduced Asia imports enabling customers to buy available production

Business Development

  • rPET: Pepsi and other packaging companies/brands seeking earlier-than-original-contract PET/rPET purchases due to renewed product value
  • Advanced Materials / Tritan: wins with cosmetic packaging customers (named only as Tritan/cosmetic packaging category; no specific counterparties named beyond Pepsi elsewhere)

AI IconFinancial Highlights

  • January guidance for rPET/circular revenue growth of 4% to 5% still expected; management indicated possible upside but expects growth largely in 4% to 5% range unless Middle East-driven effects broaden beyond current assumptions
  • Advanced Materials: Q2 sequential earnings improvement expected; AM price actions implemented April 1 or May 1 to cover raw-material inflation (paraxylene, VAM, key inputs); back half stronger than normal due to back-half loaded circular wins and cost/energy/utilization tailwinds
  • Fibers segment: management lowered earnings guide by ~$20m due to slower yarn growth and lower asset utilization tailwind; Q2 risk noted as Middle East customers buy less than expected
  • Fibers: second half improvement expected on contract minimum compliance; management specified Middle East customers are ~10% of segment revenue and earnings risk addressed by lowering segment earnings expectations to $210m–$240m
  • Chemical Intermediates: guided Q2 EBIT around ~$50m; Q3 expected to be similar rather than substantially higher due to margin tightness and Strait-of-Hormuz/tanker/market tightness timing uncertainty
  • Pricing actions: ~$500m of price increases started; specialty segment pricing mid-single-digit Q1 to Q2, while Chemical Intermediates phasing in high teens approaching 20% sequential momentum
  • IEEPA tariff refunds and winter storm: recognized about $20m within Q1 for IEEPA tariffs; management stated winter storm impact and IEEPA recognition neutralize each other in Q1; no further IEEPA refunds to recognize; cash expected in second half

AI IconCapital Funding

    AI IconStrategy & Ops

    • Operational constraint/export logistics in Middle East: customers impacted by ability to export; not material availability but inability to move product constrained demand pattern (buy less in Q2, ramp in back half expected)
    • Methanolysis platform capacity/upsizing: rPET/circular growth supported by capacity ramping pace; management indicated it takes time to continue supporting growth beyond this year as PET capability ramps
    • Asset utilization and cost structure management: emphasized Q2–Q3 shutdown/tailwind dynamics in Chemical Intermediates but tempered by potential pressure if Strait opens sooner
    • Pricing governance: specialties value-based pricing held volumes; rapid execution of price changes (April 1/May 1) to keep pace with paraxylene/VAM inflation

    AI IconMarket Outlook

    • rPET/circular revenue growth: reiterated 4% to 5% expectation (January) with upside possible tied more to Middle East-related disruptions than oil/value proposition alone
    • Fibers: guide adjusted; lowered earnings expectation to $210m–$240m range for the segment
    • Chemical Intermediates: Q3 EBIT expected to be more similar to Q2 than materially higher; depends on timing of market tightening relief if the Strait opens in coming months
    • AM earnings cadence: Q2 sequential lift; back half stronger than normal with flat-to-better volumes due to innovation/wins offsetting normal seasonal decline; EPS expected above $6/share

    AI IconRisks & Headwinds

    • Middle East conflict: affects customer operating/export logistics rather than EMN supply; Q2 fibers volume risk as customers buy less than expected
    • Fibers: yarn business not growing as fast in current market context; reduced asset utilization tailwind versus earlier expectations
    • Chemical Intermediates: margin tightness; potential spread pressure if Strait opens and market tightness moderates; propane/commodity volatility included in quarterly assumptions
    • Visibility into June remains limited (wildcard) despite strong order books in March/April/May
    • Underlying demand not meaningfully improved for consumer discretionary/durables/cosmetics; growth relies on share gains/value and competitor operational constraints rather than broad end-market recovery

    Q&A: Analyst Interest

    • Methanolysis/rPET demand vs crude/virgin price run-up: Management said they still expect ~4%–5% revenue growth (circular/rPET) because end-market demand hasn’t improved, but specialty and rPET value proposition is supporting trials, premium purchases, and possible additional volume upside from operational constraints elsewhere.
    • Fibers force majeure vs contract minimums and second-half ramp: Management clarified Middle East customers are ~10% of segment revenue; the other ~90% follows contract volume commitments. Even if Middle East logistics disrupt timing, contracts historically meet volumes; Q2 risk is real, but back-half ramp drives improvement.
    • CI margin/spreads path into Q3: Management described Q2 EBIT around ~$50m with tight margins. For Q3 they expect similar results, not a clear step-up, because shutdown tailwind helps but any Strait opening could moderate spreads; timing is the key uncertainty.

    Sentiment: MIXED

    Note: This summary was synthesized by AI from the EMN Q1 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

    Loading financial data and tables...
    © 2026 Stock Market Info — Eastman Chemical Company (EMN) Financial Profile